Trends in the Treatment of Anemia Using Recombinant Human Erythropoietin in Patients with HIV Infection

BACKGROUND: Treating anemia with erythropoietin (EPO) to hemoglobin (Hb) endpoints >11 g/dL may increase risk of serious adverse cardiovascular events. METHODS: We used medical records data (1996-2003 from the Adolescent Spectrum of HIV Disease Project [ASD] and 1996-2006 from the HIV Outpatient...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sullivan, Patrick S, Hanson, Debra L, Richardson, James T, Brooks, John T
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Bentham Open 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3257553/
https://ncbi.nlm.nih.gov/pubmed/22253666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874613601105010113
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller